In a review article, Kipnis LM et al. underlined the importance of integrating genetic counseling and testing into the management of women diagnosed with atypical uterine leiomyomas, particularly for identifying women with germline FH pathogenic variants who are at increased risk for aggressive renal cell carcinoma [16]. The gene discussed is FH; the disease is Uterine leiomyoma.